Engineering theranostic nanovehicles capable of targeting cerebrovascular amyloid deposits-Reference-Cited by-同舟云学术

Engineering theranostic nanovehicles capable of targeting cerebrovascular amyloid deposits

Published:2014-07 Issue: Volume:185 Page:121-129
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Agyare Edward K.,Jaruszewski Kristen M.,Curran Geoffry L.,Rosenberg Jens T.,Grant Samuel C.,Lowe Val J.,Ramakrishnan Subramanian,Paravastu Anant K.,Poduslo Joseph F.,Kandimalla Karunya K.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference31 articles.

1. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes;Vinters;Stroke,1983

2. Cerebral amyloid angiopathy pathology and cognitive domains in older persons;Arvanitakis;Ann. Neurol,2010

3. Brain microbleeds and Alzheimer's disease: innocent observation or key player?;Cordonnier;Brain,2011

4. Tissue microstructural changes are independently associated with cognitive impairment in cerebral amyloid angiopathy;Viswanathan;Stroke,2008

5. Steroid responsive encephalopathy in cerebral amyloid angiopathy: a case report and review of evidence for immunosuppressive treatment;Kloppenborg;J. Neuroinflammation,2010

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A critical review on the role of nanotheranostics mediated approaches for targeting β amyloid in Alzheimer’s;Journal of Drug Targeting;2023-07-19

2. Machine learning assisted-nanomedicine using magnetic nanoparticles for central nervous system diseases;Nanoscale Advances;2023

3. Nanomaterial-Mediated Theranostics for Vascular Diseases;Smart Nanomaterials Targeting Pathological Hypoxia;2023

4. Therapeutic nanotechnologies for Alzheimer’s disease: A critical analysis of recent trends and findings;Advanced Drug Delivery Reviews;2022-08

5. Therapeutic and Diagnostic Applications of Nanocomposites in the Treatment Alzheimer's Disease Studies;BIOINTERFACE RES APP;2022